Corpus ID: 21484227

Gateways to clinical trials.

  title={Gateways to clinical trials.},
  author={A. Tomillero and M. A. Moral},
  journal={Methods and findings in experimental and clinical pharmacology},
  volume={32 2},
Alemtuzumab, Atomoxetine hydrochloride; BioMatrix Flex drug-eluting stent, Botulinum toxin type B, Brivaracetam, Cannabidiol, Carisbamate, Cetuximab, Ciclesonide, Daptomycin, Darunavir, Duloxetine hydrochloride, Ecallantide, Enfuvirtide, Etravirine, Everolimus-eluting coronary stent, Ezetimibe; Fluticasone furoate, FX-125L; Ghrelin (human); Idraparinux sodium; Lersivirine, Levocetirizine dihydrochloride, Levodopa/carbidopa/entacapone, Liposomal doxorubicin, LNCaP/IL-2/IFN-gamma; Morphine… Expand
Apremilast as a treatment for psoriasis
The pharmacokinetic properties of apremilast are presented, as well as available preliminary pre-clinical and clinical trial data, and an overview of its safety and efficacy are given, to fill a key need as a safe, first-line oral treatment for patients with psoriasis. Expand
Drug Interaction of Warfarin with Simvastatin/Gemfibrozil : high levels of ALT/AST, rhabdomyolysis and acute renal failure
이 증례는 드물게 보는 경우로 simvastatin과 gemfibrozil을 오랫동안 함께 복용했음에도, 특이한 문제가 발현되지 않았 지만, 이들을 warfarin와 함께 치료하는 경우, 아주 높은 alanine aminotransferase (ALT), aspartate aminotransferase (AST) 혈중 농도, rhabdomyolysis,Expand
The GluK1 (GluR5) Kainate/α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist LY293558 Reduces Soman-Induced Seizures and Neuropathology
Testing whether LY293558 is effective against soman-induced seizures and neuropathology, when administered 1 h after soman exposure, in rats found it to be effective. Expand
New therapeutic approaches to hepatitis C virus
The current status of preclinical drug development, ongoing clinical trials, and near future perspectives in the field of HCV therapeutics are reviewed. Expand
Farnesyltransferase Inhibitor in Cancer Treatment
The Ras family of proteins, which are mutationally activated in a wide range of human tumor types and are important contributors to the neoplastic phenotype, are one potential target for cancer therapy. Expand
Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging.
The studies suggest that PS exposed within the lumen of tumor vasculature is a highly specific and useful biomarker for targeted MRI contrast agents, and ionizing radiation induced a significant increase in PS exposure on tumor vascular endothelial cells. Expand
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
Results clearly demonstrate that Liraglutide and other GLP-1 analogues elicit effects on neurotransmission in the brain and are not only effective inmodulating insulin-release and achieving glycaemic control in type 2 diabetes, but are also effective in modulating synaptic plasticity. Expand
Profiling of DNA Methylation and Single Nucleotide Polymorphism for Diagnosis, Prognosis and Targeting DNA Methyltransferases for Therapeutic Intervention of Breast Cancer
This integrated study comprised of Illumina 450 DNA methylation, Affymetrix SNP array and RNAseq dataset retrieved from the Cancer genome atlas (TCGA) portal which elaborated the biological and complex outlay in the diagnosis, prognosis and therapeutic implications of breast cancer. Expand
Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.
The present review gives an overview on the serotonin (5-hydroxytryptamine; 5-HT) system, its receptors and their relationship to central nervous system physiology and disorders. Additionally, weExpand
Aberrant cytokine signaling in ovarian cancer
Assessment of IL-6R family expression represents a potential prognostic tool in determining appropriate therapy for ovarian cancer patients and has the potential to significantly impact on ovarian cancer progression. Expand